Early CytoSorb Initiation Improves Hemodynamic Stabilization and Survival in New Septic Shock Study
Early CytoSorb Initiation Improves Hemodynamic Stabilization and Survival in New Septic Shock Study MONMOUTH JUNCTION, N.J. , Dec. 9, 2020 /PRNewswire/ — CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its CytoSorb ® more...
NASDAQ: FLDM Investor Notice: Lawsuit against Fluidigm Corporation announced by Shareholders Foundation
SAN DIEGO, Dec. 08, 2020 (GLOBE NEWSWIRE) — The Shareholders Foundation, Inc. announces that a lawsuit was filed for certain investors in NASDAQ: FLDM shares. Investors, who purchased shares of Fluidigm Corporation (NASDAQ: FLDM) prior more...
Flexion Therapeutics to Present at the Needham Virtual Epilepsy and Pain Specialty CNS Therapeutics Conference
BURLINGTON, Mass., Dec. 07, 2020 (GLOBE NEWSWIRE) — Flexion Therapeutics, Inc. (Nasdaq:FLXN) announced today that Michael Clayman, M.D., President and Chief Executive Officer, will participate in an analyst-led fireside chat at the Needham Virtual Epilepsy more...
The Zacks Analyst Blog Highlights: Quest Diagnostics, Laboratory Corporation of America, Hologic, IDEXX Laboratories and Thermo Fisher Scientific
For Immediate Release Chicago, IL – December 7, 2020 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting more...
DURECT Corporation to Sell its LACTEL® Absorbable Polymer Product Line to Evonik for $15 Million
DURECT Corporation to Sell its LACTEL® Absorbable Polymer Product Line to Evonik for $15 Million CUPERTINO, Calif. , Dec. 7, 2020 /PRNewswire/ — DURECT Corporation (Nasdaq: DRRX) today announced that it has signed an agreement more...
Avadel Pharmaceuticals Appoints Dr. Jennifer Gudeman as Vice President of Medical and Clinical Affairs
DUBLIN, Ireland, Dec. 07, 2020 (GLOBE NEWSWIRE) — Avadel Pharmaceuticals plc (Nasdaq: AVDL), a company focused on developing FT218, an investigational, once-nightly formulation of sodium oxybate designed to treat excessive daytime sleepiness and cataplexy in patients more...
Emergent Biosolutions (EBS) Down 14.7% Since Last Earnings Report: Can It Rebound?
A month has gone by since the last earnings report for Emergent Biosolutions (EBS). Shares have lost about 14.7% in that time frame, underperforming the S&P 500. Will the recent negative trend continue leading up more...
Why Is Endo (ENDP) Up 10.5% Since Last Earnings Report?
It has been about a month since the last earnings report for Endo International (ENDP). Shares have added about 10.5% in that time frame, outperforming the S&P 500. Will the recent positive trend continue leading more...
Why Is Aerie (AERI) Up 19% Since Last Earnings Report?
A month has gone by since the last earnings report for Aerie Pharmaceuticals (AERI). Shares have added about 19% in that time frame, outperforming the S&P 500. Will the recent positive trend continue leading up more...